The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab plus docetaxel for patients with metastatic castration-resistant prostate cancer (mCRPC): Randomized, double-blind, phase 3 KEYNOTE-921 study.
 
Daniel P. Petrylak
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; Astellas Pharma; AstraZeneca; Bayer; Bicycle Therapeutics; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Exelixis; Gilead Sciences; Incyte; Ipsen; Janssen; Lilly; Mirati Therapeutics; Monopteros Therapeutics; Pfizer; Pharmacyclics; Regeneron; Roche; Seagen; Urogen pharma
Research Funding - Advanced Accelerator Applications (Inst); Agensys (Inst); Astellas Medivation (Inst); AstraZeneca (Inst); Bayer (Inst); BioXCel therapeutics (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Eisai (Inst); Endocyte (Inst); Genentech (Inst); Gilead Sciences (Inst); Innocrin Pharma (Inst); Lilly (Inst); MedImmune (Inst); Medivation (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Progenics (Inst); Replimune (Inst); Roche (Inst); Sanofi (Inst); Seagen (Inst)
Expert Testimony - Celgene; sanofi
 
Raffaele Ratta
Honoraria - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Ipsen; Ipsen; Ipsen; Ipsen; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; Pfizer; Pfizer; Pfizer; Pfizer
Consulting or Advisory Role - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Pfizer; Pfizer; Pfizer; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Pfizer; Pfizer; Pfizer; Pfizer
 
Nobuaki Matsubara
Honoraria - Sanofi; Sanofi; Sanofi; Sanofi
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Janssen; Janssen; Janssen; Janssen; Lilly; Lilly; Lilly; Lilly; Pfizer; Pfizer; Pfizer; Pfizer; Sanofi; Sanofi; Sanofi; Sanofi; Seagen; Seagen; Seagen; Seagen
Research Funding - Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer Yakuhin (Inst); Bayer Yakuhin (Inst); Bayer Yakuhin (Inst); Bayer Yakuhin (Inst); Chugai Pharma (Inst); Chugai Pharma (Inst); Chugai Pharma (Inst); Chugai Pharma (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Janssen (Inst); Janssen (Inst); Janssen (Inst); Janssen (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); MSD (Inst); MSD (Inst); MSD (Inst); MSD (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst)
 
Ernesto Pablo Korbenfeld
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Lilly; Lilly; Lilly; Lilly; MSD; MSD; MSD; MSD; Pfizer; Pfizer; Pfizer; Pfizer; Roche; Roche; Roche; Roche
Speakers' Bureau - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; EMS; EMS; EMS; EMS; Lilly; Lilly; Lilly; Lilly; Pfizer; Pfizer; Pfizer; Pfizer
Travel, Accommodations, Expenses - MSD; MSD; MSD; MSD
 
Rustem Gafanov
Honoraria - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Janssen; Janssen; Janssen; Janssen; MSD; MSD; MSD; MSD; Pfizer; Pfizer; Pfizer; Pfizer; Sanofi; Sanofi; Sanofi; Sanofi
Consulting or Advisory Role - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Janssen; Janssen; Janssen; Janssen; MSD; MSD; MSD; MSD; Pfizer; Pfizer; Pfizer; Pfizer; Sanofi; Sanofi; Sanofi; Sanofi
Speakers' Bureau - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Janssen; Janssen; Janssen; Janssen; MSD; MSD; MSD; MSD; Pfizer; Pfizer; Pfizer; Pfizer; Sanofi; Sanofi; Sanofi; Sanofi
 
Loic Mourey
Honoraria - Amgen; Amgen; Amgen; Amgen; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Ipsen; Ipsen; Ipsen; Ipsen; Janssen; Janssen; Janssen; Janssen; Pfizer; Pfizer; Pfizer; Pfizer; Sanofi; Sanofi; Sanofi; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; BMS; BMS; BMS; BMS; Ipsen; Ipsen; Ipsen; Ipsen; janssen; janssen; janssen; janssen; Pfizer; Pfizer; Pfizer; Pfizer; Sanofi; Sanofi; Sanofi; Sanofi
 
Tilman Todenhöfer
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca/Merck; AstraZeneca/Merck; AstraZeneca/Merck; AstraZeneca/Merck; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb/Sanofi; Bristol-Myers Squibb/Sanofi; Bristol-Myers Squibb/Sanofi; Bristol-Myers Squibb/Sanofi; Janssen; Janssen; Janssen; Janssen; Merck Serono; Merck Serono; Merck Serono; Merck Serono; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; Pfizer; Pfizer; Pfizer; Pfizer; Roche; Roche; Roche; Roche; Sanofi/Aventis; Sanofi/Aventis; Sanofi/Aventis; Sanofi/Aventis
Research Funding - Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); Basilea (Inst); Basilea (Inst); Basilea (Inst); Basilea (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Immunomedics (Inst); Immunomedics (Inst); Immunomedics (Inst); Immunomedics (Inst); Janssen (Inst); Janssen (Inst); Janssen (Inst); Janssen (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); MSD Oncology (Inst); MSD Oncology (Inst); MSD Oncology (Inst); MSD Oncology (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); RhoVac (Inst); RhoVac (Inst); RhoVac (Inst); RhoVac (Inst)
 
Howard Gurney
Consulting or Advisory Role - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Ipsen; Ipsen; Ipsen; Ipsen; Janssen-Cilag; Janssen-Cilag; Janssen-Cilag; Janssen-Cilag; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Pfizer; Pfizer; Pfizer; Pfizer; Roche; Roche; Roche; Roche
Speakers' Bureau - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Merck Serono; Merck Serono; Merck Serono; Merck Serono
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca
 
Gero Kramer
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Ferring; Ferring; Ferring; Ferring; Ipsen; Ipsen; Ipsen; Ipsen; Janssen; Janssen; Janssen; Janssen; MSD; MSD; MSD; MSD; Novartis; Novartis; Novartis; Novartis; Sanofi/Aventis; Sanofi/Aventis; Sanofi/Aventis; Sanofi/Aventis
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Ferring; Ferring; Ferring; Ferring; Ipsen; Ipsen; Ipsen; Ipsen; Janssen; Janssen; Janssen; Janssen; MSD; MSD; MSD; MSD; Novartis; Novartis; Novartis; Novartis; Sanofi/Aventis; Sanofi/Aventis; Sanofi/Aventis; Sanofi/Aventis
 
Andre M. Bergman
Consulting or Advisory Role - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Bayer; Bayer; Bayer; Bayer; Janssen; Janssen; Janssen; Janssen; Sanofi; Sanofi; Sanofi; Sanofi
Research Funding - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Bayer; Bayer; Bayer; Bayer
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer; Bayer
 
Pawel Zalewski
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; BMS; BMS; BMS; BMS; Ipsen; Ipsen; Ipsen; Ipsen; Merck; Merck; Merck; Merck; Novartis; Novartis; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Pfizer
Research Funding - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; BMS; BMS; BMS; BMS; Clovis Oncology; Clovis Oncology; Clovis Oncology; Clovis Oncology; Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; Merck; Merck; Merck; Merck; Seagen; Seagen; Seagen; Seagen
 
Maria De Santis
Honoraria - AAA HealthCare; AAA HealthCare; AAA HealthCare; AAA HealthCare; Accord Healthcare; Accord Healthcare; Accord Healthcare; Accord Healthcare; Amgen; Amgen; Amgen; Amgen; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; Basilea; Basilea; Basilea; Basilea; Bayer; Bayer; Bayer; Bayer; BioClin Therapeutics; BioClin Therapeutics; BioClin Therapeutics; BioClin Therapeutics; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Exelixis/Ipsen; Exelixis/Ipsen; Exelixis/Ipsen; Exelixis/Ipsen; Ferring; Ferring; Ferring; Ferring; Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; Immunomedics; Immunomedics; Immunomedics; Immunomedics; Ipsen; Ipsen; Ipsen; Ipsen; Janssen-Cilag; Janssen-Cilag; Janssen-Cilag; Janssen-Cilag; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; Novartis; Novartis; Novartis; Novartis; Orion; Orion; Orion; Orion; Pfizer; Pfizer; Pfizer; Pfizer; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; Sandoz-Novartis; Sandoz-Novartis; Sandoz-Novartis; Sandoz-Novartis; Sanofi; Sanofi; Sanofi; Sanofi; Seagen; Seagen; Seagen; Seagen
Consulting or Advisory Role - AAA HealthCare; AAA HealthCare; AAA HealthCare; AAA HealthCare; Accord Healthcare; Accord Healthcare; Accord Healthcare; Accord Healthcare; Amgen; Amgen; Amgen; Amgen; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Basilea; Basilea; Basilea; Basilea; Bayer; Bayer; Bayer; Bayer; BioClin Therapeutics; BioClin Therapeutics; BioClin Therapeutics; BioClin Therapeutics; BioSyn Healthy Pharma; BioSyn Healthy Pharma; BioSyn Healthy Pharma; BioSyn Healthy Pharma; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Ferring; Ferring; Ferring; Ferring; Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Ipsen; Ipsen; Ipsen; Ipsen; Janssen; Janssen; Janssen; Janssen; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Novartis; Novartis; Novartis; Novartis; Pierre Fabre; Pierre Fabre; Pierre Fabre; Pierre Fabre; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; Sandoz-Novartis; Sandoz-Novartis; Sandoz-Novartis; Sandoz-Novartis; Sanofi; Sanofi; Sanofi; Sanofi; Seagen; Seagen; Seagen; Seagen; Takeda; Takeda; Takeda; Takeda
Travel, Accommodations, Expenses - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Ipsen; Ipsen; Ipsen; Ipsen; Janssen; Janssen; Janssen; Janssen; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Roche; Roche; Roche; Roche; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; Sanofi; Sanofi; Sanofi; Sanofi
 
Andrew J. Armstrong
Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc; Astellas Scientific and Medical Affairs Inc; Astellas Scientific and Medical Affairs Inc; Astellas Scientific and Medical Affairs Inc; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Epic Sciences; Epic Sciences; Epic Sciences; Epic Sciences; Exelixis; Exelixis; Exelixis; Exelixis; FORMA Therapeutics; FORMA Therapeutics; FORMA Therapeutics; FORMA Therapeutics; GoodRx; GoodRx; GoodRx; GoodRx; IDEAYA Biosciences; IDEAYA Biosciences; IDEAYA Biosciences; IDEAYA Biosciences; Janssen; Janssen; Janssen; Janssen; Merck; Merck; Merck; Merck; Myovant Sciences; Myovant Sciences; Myovant Sciences; Myovant Sciences; Novartis; Novartis; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Pfizer
Research Funding - Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); BeiGene (Inst); BeiGene (Inst); BeiGene (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Constellation Pharmaceuticals (Inst); Constellation Pharmaceuticals (Inst); Constellation Pharmaceuticals (Inst); Constellation Pharmaceuticals (Inst); Dendreon (Inst); Dendreon (Inst); Dendreon (Inst); Dendreon (Inst); FORMA Therapeutics (Inst); FORMA Therapeutics (Inst); FORMA Therapeutics (Inst); FORMA Therapeutics (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst); Circulating tumor cell novel capture technology (Inst); Circulating tumor cell novel capture technology (Inst); Circulating tumor cell novel capture technology (Inst)
Travel, Accommodations, Expenses - Astellas Scientific and Medical Affairs Inc; Astellas Scientific and Medical Affairs Inc; Astellas Scientific and Medical Affairs Inc; Astellas Scientific and Medical Affairs Inc
 
Winald R. Gerritsen
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; IMS Health; IMS Health; IMS Health; IMS Health; Janssen-Cilag; Janssen-Cilag; Janssen-Cilag; Janssen-Cilag; MSD; MSD; MSD; MSD; Sanofi; Sanofi; Sanofi; Sanofi
Speakers' Bureau - ESMO Open; ESMO Open; ESMO Open; ESMO Open; MSD; MSD; MSD; MSD
Research Funding - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Bayer; Bayer; Bayer; Bayer; Janssen-Cilag; Janssen-Cilag; Janssen-Cilag; Janssen-Cilag; Sanofi; Sanofi; Sanofi; Sanofi
 
Russell Kent Pachynski
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Blue Earth Diagnostics; Blue Earth Diagnostics; Blue Earth Diagnostics; Blue Earth Diagnostics; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Dendreon; Dendreon; Dendreon; Dendreon; EMD Serono; EMD Serono; EMD Serono; EMD Serono; Genomic Health; Genomic Health; Genomic Health; Genomic Health; Jounce Therapeutics; Jounce Therapeutics; Jounce Therapeutics; Jounce Therapeutics; Pfizer/EMD Serono; Pfizer/EMD Serono; Pfizer/EMD Serono; Pfizer/EMD Serono; Sanofi; Sanofi; Sanofi; Sanofi
Speakers' Bureau - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Dendreon; Dendreon; Dendreon; Dendreon; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genomic Health; Genomic Health; Genomic Health; Genomic Health; Merck; Merck; Merck; Merck; Sanofi; Sanofi; Sanofi; Sanofi
Research Funding - Bristol Myers Squibb Foundation (Inst); Bristol Myers Squibb Foundation (Inst); Bristol Myers Squibb Foundation (Inst); Bristol Myers Squibb Foundation (Inst); Exelixis (Inst); Exelixis (Inst); Exelixis (Inst); Exelixis (Inst); Janssen Oncology; Janssen Oncology; Janssen Oncology; Janssen Oncology; Pharmacyclics (Inst); Pharmacyclics (Inst); Pharmacyclics (Inst); Pharmacyclics (Inst)
Patents, Royalties, Other Intellectual Property - Entitled: METHOD OF CELL-FREE DNA ANALYSIS TO IDENTIFY HIGH-RISK METASTATIC PROSTATE CANCER; Entitled: METHOD OF CELL-FREE DNA ANALYSIS TO IDENTIFY HIGH-RISK METASTATIC PROSTATE CANCER; Entitled: METHOD OF CELL-FREE DNA ANALYSIS TO IDENTIFY HIGH-RISK METASTATIC PROSTATE CANCER; Entitled: METHOD OF CELL-FREE DNA ANALYSIS TO IDENTIFY HIGH-RISK METASTATIC PROSTATE CANCER
Travel, Accommodations, Expenses - Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche
 
Seok-Soo Byun
Leadership - Health Connect; Health Connect; Health Connect; Health Connect; Procagen; Procagen; Procagen; Procagen
Stock and Other Ownership Interests - At Sense; At Sense; At Sense; At Sense
Consulting or Advisory Role - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Janssen; Janssen; Janssen; Janssen
Patents, Royalties, Other Intellectual Property - Procagen; Procagen; Procagen; Procagen
 
Xin Tong Li
Employment - Merck; Merck; Merck; Merck
Stock and Other Ownership Interests - Merck; Merck; Merck; Merck
 
Charles Schloss
Employment - Merck; Merck; Merck; Merck
Stock and Other Ownership Interests - Merck; Merck; Merck; Merck
 
Christian Heinrich Poehlein
Employment - Merck; Merck; Merck; Merck
Leadership - Merck; Merck; Merck; Merck
Stock and Other Ownership Interests - Merck; Merck; Merck; Merck
Travel, Accommodations, Expenses - Merck; Merck; Merck; Merck
 
Karim Fizazi
Honoraria - Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Janssen (Inst); Janssen (Inst); Janssen (Inst); Janssen (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst)
Consulting or Advisory Role - Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); ESSA (Inst); ESSA (Inst); ESSA (Inst); ESSA (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Orion; Orion; Orion; Orion; Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Janssen; Janssen; Janssen; Janssen; MSD; MSD; MSD; MSD